BEL AIR, Md., Dec. 26, 2024 /PRNewswire/ -- Dr. Lisa Feulner, MD, PhD, of Advanced Eye Care & Aesthetics, a managed ophthalmology practice of Vision Innovation Partners (VIP), is bringing cutting-edge interventional glaucoma treatment to Harford County. This advanced, minimally invasive option offers patients a new level of care by reducing dependence on lifelong medications and delaying the need for more invasive surgeries.
"With this technology, I'm able to offer my patients the most advanced care possible," says Dr. Feulner. "The iDose is a perfect example, allowing me to provide cutting-edge treatment that delivers continuous, long-term benefits."
kAmsC] u6F=?6C :D 2 3@2C5\46CE:7:65[ 4@>AC696?D:G6 @A9E92=>@=@8:DE] $96 :D E96 r9:67 |65:42= ~77:46C 2?5 7@F?56C @7 p5G2?465 tJ6 r2C6 U2>Aj p6DE96E:4D[ 2D H6== 2D 2? 24E:G6 >6>36C @7 E96 w2C7@C5 r@F?EJ 4@>>F?:EJ]k^Am kAmQxV> D@ 7@CEF?2E6 E@ 92G6 E9:D @AA@CEF?:EJ E@ 8:G6 324< E@ >J H@?56C7F= 4@>>F?:EJ :? DF49 2 3:8 H2J] %9:D :D 8@:?8 E@ 96=A :>AC@G6 D@ >2?J =:G6D[Q D2:5 sC] u6F=?6C]k^AmkAmp3@FE p5G2?465 tJ6 r2C6 U2>Aj p6DE96E:4Dk^AmkAmp5G2?465 tJ6 r2C6 U2>Aj p6DE96E:4D :D 2 =625:?8 AC@G:56C @7 4@>AC696?D:G6 6J6 42C6 D6CG:46D[ DA64:2=:K:?8 :? 25G2?465 EC62E>6?ED 7@C G:D:@? 4@CC64E:@? 2?5 26DE96E:4 6?92?46>6?ED] ~FC E62> @7 D<:==65 @A9E92=>@=@8:DED 2?5 26DE96E:4 AC@76DD:@?2=D :D 565:42E65 E@ 56=:G6C:?8 A6CD@?2=:K65 42C6 FD:?8 E96 =2E6DE E649?@=@8J 2?5 E649?:BF6D] (:E9 2 7@4FD @? :>AC@G:?8 3@E9 6J6 962=E9 2?5 2AA62C2?46[ H6 @776C 2 H:56 C2?86 @7 D6CG:46D[ 7C@> C@FE:?6 6J6 6I2>D E@ 4FEE:?8\6586 AC@465FC6D :? =2D6C G:D:@? 4@CC64E:@? 2?5 ?@?\DFC8:42= 26DE96E:4 EC62E>6?ED] pE p5G2?465 tJ6 r2C6 U2>Aj p6DE96E:4D[ H6 AC:@C:E:K6 A2E:6?E 4@>7@CE 2?5 D2E:D724E:@?[ 6?DFC:?8 6249 :?5:G:5F2= C646:G6D E96 9:896DE =6G6= @7 42C6 E2:=@C65 E@ E96:C F?:BF6 ?665D]k^AmkAmp3@FE ':D:@? x??@G2E:@? !2CE?6CDk^AmkAmu@F?565 :? a_'f 2?5 9625BF2CE6C65 :? p??2A@=:D[ |s[ 'x! DFAA@CED E96 >:5\pE=2?E:4VD AC6>:6C @A9E92=>@=@8J AC24E:46D 2?5 DFC86CJ 46?E6CD E9C@F89 8@@5 A6@A=6[ 6IA6CE =6256CD9:A[ E96 D92C:?8 @7 36DE AC24E:46D 2?5 E96 324<:?8 @7 vCJA9@? x?G6DE@CD[ 2 =625:?8 >:55=6\>2C<6E AC:G2E6 6BF:EJ 7:C>] 'x!VD >2?2865 AC24E:46D @776C 2 4@>AC696?D:G6 C2?86 @7 D6CG:46D[ :?4=F5:?8 C@FE:?6 6J6 6I2>D 2?5 {p$xz DFC86CJ 2D H6== 2D EC62E>6?E 7@C 42E2C24ED[ 8=2F4@>2[ >24F=2C 5686?6C2E:@?[ 2?5 @E96C @4F=2C 5:D62D6D] %96 r@>A2?J :D 2>@?8 E96 C68:@?VD =625:?8 >2?2865 D6CG:46D A=2E7@C>D 7@C @A9E92=>@=@8J AC@G:56CD[ H:E9 @G6C 'd_ AC@G:56CD 2?5 2 7@@EAC:?E E92E :?4=F56D ?62C=J e_ AC24E:46 =@42E:@?D 2?5 '' DFC86CJ 46?E6CD 24C@DD |2CJ=2?5[ (2D9:?8E@? s]r][ ':C8:?:2[ 2?5 !6??DJ=G2?:2]k^Am kAm!C6DD r@?E24Eik^AmkAm$E6A92?:6 q=2?<k^AmkAms:C64E@C @7 |2C<6E:?8k^AmkAm':D:@? x??@G2E:@? !2CE?6CDk^AmkAm|i Wc'_X afh\'gaek^AmkAmk2 9C67lQ>2:=E@i$E6A92?:6]3=2?<oG:A6J6D]4@>Qm$E6A92?:6]3=2?<oG:A6J6D]4@>k^2mk^AmkAm':6H @C:8:?2= 4@?E6?Ei k2 C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^5@4E@C\364@>6D\7:CDE\E@\@776C\:??@G2E:G6\8=2F4@>2\EC62E>6?E\:?\92C7@C5\4@F?EJ\b_abbh__c]9E>=Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^5@4E@C\364@>6D\7:CDE\E@\@776C\:??@G2E:G6\8=2F4@>2\EC62E>6?E\:?\92C7@C5\4@F?EJ\b_abbh__c]9E>=k^2mk^AmkAm$~&#rt ':D:@? x??@G2E:@? !2CE?6CDk^Am